Chronic Pain: Study Reveals Biological Basis for Longer Duration in Women

For decades, women reporting chronic pain have faced a frustrating hurdle: being told their suffering is psychological, not physiological. Now, a new study offers compelling evidence that the difference in pain experience between men and women isn’t “all in your head,” but rooted in biological differences within the immune system. The research, published in Science Immunology, sheds light on why chronic pain often lasts longer in women, and could pave the way for more targeted and effective treatments.

A Biological Basis for Pain Disparity

The study, led by Geoffroy Laumet, focused on monocytes – hormone-regulated immune cells that play a crucial role in resolving inflammation and, pain. Researchers discovered that these cells function differently in males and females. When pain occurs, neurons react to stimuli, like an injury. But chronic pain persists even without ongoing stimulation, and women are disproportionately affected, constituting 60% to 70% of those experiencing it.

Laumet explained to AFP, “The pain of women has been overlooked in clinical practice, with the idea that it’s more in the mind, or that it’s because women are softer and more emotional.” However, the study demonstrates a “real biological mechanism” behind the disparity. The team found that in female mice, monocytes were less effective at producing interleukin 10 (IL-10), an anti-inflammatory molecule that helps shut down pain-sensing neurons. This slower production of IL-10 resulted in prolonged pain duration.

Interestingly, the research wasn’t initially designed to explore sex-based differences. The team was investigating how monocytes impact pain resolution generally, but the data clearly revealed a divergence. Male mice exhibited more active monocytes and higher levels of IL-10 production, a difference attributed to higher levels of sex hormones like testosterone, according to the study.

Beyond Mice: Implications for Human Health

While the study was conducted on mice, the findings have significant implications for understanding chronic pain in humans. Elora Midavaine, a researcher at the University of California, San Francisco who studies chronic pain (but was not involved in this study), told AFP that the research adds “important nuance” to our understanding of the complex interplay between hormones, the immune system, and pain perception. She noted that it aligns with a growing trend in neuroscience that integrates immunology and endocrinology, potentially leading to breakthroughs in chronic pain management for women.

The potential for new treatments is promising. Laumet hopes the research will open doors to strategies for stimulating monocytes and boosting IL-10 production, enhancing the body’s natural pain-resolving capabilities. In the short term, he suggests topical testosterone could be a viable option for alleviating localized pain. However, it’s crucial to remember that this is preliminary, and further research is needed to determine the safety and efficacy of such approaches in humans.

A History of Exclusion and Bias

The study’s findings are particularly poignant given the historical exclusion of women from clinical trials and pain research. For decades, women were often excluded from studies, or research focused primarily on reproductive health. Even when women were included, the assumption that female hormones created “too much variability” led to their data being dismissed or underanalyzed. This bias, as highlighted in a recent article in Lancet Regional Health – Americas, has contributed to a significant gap in our understanding of women’s health.

diagnosis of pain often relies heavily on patient self-reporting. Unfortunately, women’s symptoms are frequently interpreted as emotional or psychological rather than having a biological basis. This can lead to delayed diagnosis, inadequate treatment, and a dismissal of their genuine suffering.

Shifting the Landscape of Pain Management

Fortunately, the landscape is changing. As scientific understanding evolves, there’s a growing recognition of the importance of considering sex-specific differences in pain research and treatment. Both Laumet and Midavaine expressed optimism that this improved knowledge will lead to more equitable care for women. Laumet emphasized the need to adapt the standard of care to account for sex, and to challenge the common misconception that women’s pain is exaggerated.

This shift in perspective could too reduce reliance on opioid painkillers, which carry significant risks of side effects and addiction. By developing more targeted and effective treatments based on a deeper understanding of the biological mechanisms underlying pain, clinicians may be able to offer women safer and more sustainable pain relief options.

What’s Next for Pain Research?

The findings from this study represent a crucial step forward, but further research is essential. Scientists need to investigate how these immune system differences translate to human populations, and explore the potential of various therapeutic interventions. Clinical trials are needed to assess the safety and efficacy of approaches like topical testosterone or strategies to boost IL-10 production.

Beyond treatment, ongoing research will focus on refining our understanding of the complex interactions between hormones, the immune system, and the nervous system in pain perception. This includes exploring the role of other immune cells and signaling pathways, and investigating how genetic factors may contribute to sex-based differences in pain sensitivity. The National Institutes of Health (NIH) is increasingly prioritizing research into women’s health, including pain management, with several initiatives aimed at addressing the historical gaps in knowledge. Medical Xpress reports that this study is part of a broader effort to validate women’s experiences with pain and develop more effective treatments.

the goal is to move towards a more personalized and equitable approach to pain management, one that recognizes and addresses the unique biological factors that influence pain experience in both men and women.